世界の経粘膜ドラッグデリバリー市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Transmucosal Drug Delivery Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14454 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、経粘膜ドラッグデリバリーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経粘膜ドラッグデリバリーの種類別市場規模（パッシブ経皮ドラッグデリバリー、アクティブ経皮ドラッグデリバリー）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経粘膜ドラッグデリバリーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：3M Pharmaceuticals、Acrux Limited、ALZA Corporation、Antares Pharma, Inc.、Apricus BioSciences, Inc、Aveva Drug Delivery Systems、Corium International, Inc、DURECT Corporation、Generex Biotechnology Corporation、Inovio Pharmaceuticals, Inc.、Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)、MedPharm LTD、Mylan, Inc.、Nemaura Pharma Ltd、Nitto Denko Corporation、Noven Pharmaceuticals, Inc.、Pantec Biosolutions AG、Tapemark、tesa Labtec GmbH、TEVA Pharmaceutical Industries Ltd.、Zosano Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：パッシブ経皮ドラッグデリバリー、アクティブ経皮ドラッグデリバリー ・用途別分析2016年-2026年：病院、クリニック、その他 ・経粘膜ドラッグデリバリーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経粘膜ドラッグデリバリーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経粘膜ドラッグデリバリーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経粘膜ドラッグデリバリーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経粘膜ドラッグデリバリーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Transmucosal Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Transmucosal Drug Delivery size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Transmucosal Drug Delivery market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Transmucosal Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery

Market segment by Application, can be divided into
Hospital
Clinic
Others

Market segment by players, this report covers
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Transmucosal Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Transmucosal Drug Delivery, with revenue, gross margin and global market share of Transmucosal Drug Delivery from 2019 to 2021.
Chapter 3, the Transmucosal Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Transmucosal Drug Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Transmucosal Drug Delivery research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Transmucosal Drug Delivery
1.2 Classification of Transmucosal Drug Delivery by Type
1.2.1 Overview: Global Transmucosal Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Transmucosal Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Passive Transdermal Drug Delivery
1.2.4 Active Transdermal Drug Delivery
1.3 Global Transmucosal Drug Delivery Market by Application
1.3.1 Overview: Global Transmucosal Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Transmucosal Drug Delivery Market Size & Forecast
1.5 Global Transmucosal Drug Delivery Market Size and Forecast by Region
1.5.1 Global Transmucosal Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Transmucosal Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Transmucosal Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Transmucosal Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Transmucosal Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Transmucosal Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Transmucosal Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Transmucosal Drug Delivery Market Drivers
1.6.2 Transmucosal Drug Delivery Market Restraints
1.6.3 Transmucosal Drug Delivery Trends Analysis
2 Company Profiles
2.1 3M Pharmaceuticals
2.1.1 3M Pharmaceuticals Details
2.1.2 3M Pharmaceuticals Major Business
2.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Product and Solutions
2.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 3M Pharmaceuticals Recent Developments and Future Plans
2.2 Acrux Limited
2.2.1 Acrux Limited Details
2.2.2 Acrux Limited Major Business
2.2.3 Acrux Limited Transmucosal Drug Delivery Product and Solutions
2.2.4 Acrux Limited Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Acrux Limited Recent Developments and Future Plans
2.3 ALZA Corporation
2.3.1 ALZA Corporation Details
2.3.2 ALZA Corporation Major Business
2.3.3 ALZA Corporation Transmucosal Drug Delivery Product and Solutions
2.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ALZA Corporation Recent Developments and Future Plans
2.4 Antares Pharma, Inc.
2.4.1 Antares Pharma, Inc. Details
2.4.2 Antares Pharma, Inc. Major Business
2.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Product and Solutions
2.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Antares Pharma, Inc. Recent Developments and Future Plans
2.5 Apricus BioSciences, Inc
2.5.1 Apricus BioSciences, Inc Details
2.5.2 Apricus BioSciences, Inc Major Business
2.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Product and Solutions
2.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Apricus BioSciences, Inc Recent Developments and Future Plans
2.6 Aveva Drug Delivery Systems
2.6.1 Aveva Drug Delivery Systems Details
2.6.2 Aveva Drug Delivery Systems Major Business
2.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Product and Solutions
2.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Aveva Drug Delivery Systems Recent Developments and Future Plans
2.7 Corium International, Inc
2.7.1 Corium International, Inc Details
2.7.2 Corium International, Inc Major Business
2.7.3 Corium International, Inc Transmucosal Drug Delivery Product and Solutions
2.7.4 Corium International, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Corium International, Inc Recent Developments and Future Plans
2.8 DURECT Corporation
2.8.1 DURECT Corporation Details
2.8.2 DURECT Corporation Major Business
2.8.3 DURECT Corporation Transmucosal Drug Delivery Product and Solutions
2.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 DURECT Corporation Recent Developments and Future Plans
2.9 Generex Biotechnology Corporation
2.9.1 Generex Biotechnology Corporation Details
2.9.2 Generex Biotechnology Corporation Major Business
2.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Product and Solutions
2.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Generex Biotechnology Corporation Recent Developments and Future Plans
2.10 Inovio Pharmaceuticals, Inc.
2.10.1 Inovio Pharmaceuticals, Inc. Details
2.10.2 Inovio Pharmaceuticals, Inc. Major Business
2.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
2.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Inovio Pharmaceuticals, Inc. Recent Developments and Future Plans
2.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
2.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Details
2.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Major Business
2.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product and Solutions
2.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments and Future Plans
2.12 MedPharm LTD
2.12.1 MedPharm LTD Details
2.12.2 MedPharm LTD Major Business
2.12.3 MedPharm LTD Transmucosal Drug Delivery Product and Solutions
2.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 MedPharm LTD Recent Developments and Future Plans
2.13 Mylan, Inc.
2.13.1 Mylan, Inc. Details
2.13.2 Mylan, Inc. Major Business
2.13.3 Mylan, Inc. Transmucosal Drug Delivery Product and Solutions
2.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Mylan, Inc. Recent Developments and Future Plans
2.14 Nemaura Pharma Ltd
2.14.1 Nemaura Pharma Ltd Details
2.14.2 Nemaura Pharma Ltd Major Business
2.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Product and Solutions
2.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Nemaura Pharma Ltd Recent Developments and Future Plans
2.15 Nitto Denko Corporation
2.15.1 Nitto Denko Corporation Details
2.15.2 Nitto Denko Corporation Major Business
2.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Product and Solutions
2.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Nitto Denko Corporation Recent Developments and Future Plans
2.16 Noven Pharmaceuticals, Inc.
2.16.1 Noven Pharmaceuticals, Inc. Details
2.16.2 Noven Pharmaceuticals, Inc. Major Business
2.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
2.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Noven Pharmaceuticals, Inc. Recent Developments and Future Plans
2.17 Pantec Biosolutions AG
2.17.1 Pantec Biosolutions AG Details
2.17.2 Pantec Biosolutions AG Major Business
2.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Product and Solutions
2.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Pantec Biosolutions AG Recent Developments and Future Plans
2.18 Tapemark
2.18.1 Tapemark Details
2.18.2 Tapemark Major Business
2.18.3 Tapemark Transmucosal Drug Delivery Product and Solutions
2.18.4 Tapemark Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Tapemark Recent Developments and Future Plans
2.19 tesa Labtec GmbH
2.19.1 tesa Labtec GmbH Details
2.19.2 tesa Labtec GmbH Major Business
2.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Product and Solutions
2.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 tesa Labtec GmbH Recent Developments and Future Plans
2.20 TEVA Pharmaceutical Industries Ltd.
2.20.1 TEVA Pharmaceutical Industries Ltd. Details
2.20.2 TEVA Pharmaceutical Industries Ltd. Major Business
2.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product and Solutions
2.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 TEVA Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.21 Zosano Pharma
2.21.1 Zosano Pharma Details
2.21.2 Zosano Pharma Major Business
2.21.3 Zosano Pharma Transmucosal Drug Delivery Product and Solutions
2.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Zosano Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transmucosal Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Transmucosal Drug Delivery Players Market Share
3.2.2 Top 10 Transmucosal Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Transmucosal Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Transmucosal Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Transmucosal Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Transmucosal Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Transmucosal Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Transmucosal Drug Delivery Revenue by Type (2016-2026)
6.2 North America Transmucosal Drug Delivery Revenue by Application (2016-2026)
6.3 North America Transmucosal Drug Delivery Market Size by Country
6.3.1 North America Transmucosal Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Transmucosal Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Transmucosal Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Transmucosal Drug Delivery Market Size by Country
7.3.1 Europe Transmucosal Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Transmucosal Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Transmucosal Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Transmucosal Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Transmucosal Drug Delivery Revenue by Type (2016-2026)
9.2 South America Transmucosal Drug Delivery Revenue by Application (2016-2026)
9.3 South America Transmucosal Drug Delivery Market Size by Country
9.3.1 South America Transmucosal Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Transmucosal Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Transmucosal Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Transmucosal Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Transmucosal Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Transmucosal Drug Delivery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Transmucosal Drug Delivery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Transmucosal Drug Delivery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Transmucosal Drug Delivery Revenue (USD Million) by Region (2016-2021)
Table 5. Global Transmucosal Drug Delivery Revenue Market Share by Region (2021-2026)
Table 6. 3M Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. 3M Pharmaceuticals Major Business
Table 8. 3M Pharmaceuticals Transmucosal Drug Delivery Product and Solutions
Table 9. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Acrux Limited Corporate Information, Head Office, and Major Competitors
Table 11. Acrux Limited Major Business
Table 12. Acrux Limited Transmucosal Drug Delivery Product and Solutions
Table 13. Acrux Limited Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ALZA Corporation Corporate Information, Head Office, and Major Competitors
Table 15. ALZA Corporation Major Business
Table 16. ALZA Corporation Transmucosal Drug Delivery Product and Solutions
Table 17. ALZA Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Antares Pharma, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Antares Pharma, Inc. Major Business
Table 20. Antares Pharma, Inc. Transmucosal Drug Delivery Product and Solutions
Table 21. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Apricus BioSciences, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Apricus BioSciences, Inc Major Business
Table 24. Apricus BioSciences, Inc Transmucosal Drug Delivery Product and Solutions
Table 25. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Aveva Drug Delivery Systems Corporate Information, Head Office, and Major Competitors
Table 27. Aveva Drug Delivery Systems Major Business
Table 28. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product and Solutions
Table 29. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Corium International, Inc Corporate Information, Head Office, and Major Competitors
Table 31. Corium International, Inc Major Business
Table 32. Corium International, Inc Transmucosal Drug Delivery Product and Solutions
Table 33. Corium International, Inc Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. DURECT Corporation Corporate Information, Head Office, and Major Competitors
Table 35. DURECT Corporation Major Business
Table 36. DURECT Corporation Transmucosal Drug Delivery Product and Solutions
Table 37. DURECT Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Generex Biotechnology Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Generex Biotechnology Corporation Major Business
Table 40. Generex Biotechnology Corporation Transmucosal Drug Delivery Product and Solutions
Table 41. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Inovio Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Inovio Pharmaceuticals, Inc. Major Business
Table 44. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
Table 45. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Corporate Information, Head Office, and Major Competitors
Table 47. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Major Business
Table 48. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product and Solutions
Table 49. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. MedPharm LTD Corporate Information, Head Office, and Major Competitors
Table 51. MedPharm LTD Major Business
Table 52. MedPharm LTD Transmucosal Drug Delivery Product and Solutions
Table 53. MedPharm LTD Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Mylan, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Mylan, Inc. Major Business
Table 56. Mylan, Inc. Transmucosal Drug Delivery Product and Solutions
Table 57. Mylan, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Nemaura Pharma Ltd Corporate Information, Head Office, and Major Competitors
Table 59. Nemaura Pharma Ltd Major Business
Table 60. Nemaura Pharma Ltd Transmucosal Drug Delivery Product and Solutions
Table 61. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Nitto Denko Corporation Corporate Information, Head Office, and Major Competitors
Table 63. Nitto Denko Corporation Major Business
Table 64. Nitto Denko Corporation Transmucosal Drug Delivery Product and Solutions
Table 65. Nitto Denko Corporation Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Noven Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 67. Noven Pharmaceuticals, Inc. Major Business
Table 68. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
Table 69. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Pantec Biosolutions AG Corporate Information, Head Office, and Major Competitors
Table 71. Pantec Biosolutions AG Major Business
Table 72. Pantec Biosolutions AG Transmucosal Drug Delivery Product and Solutions
Table 73. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Tapemark Corporate Information, Head Office, and Major Competitors
Table 75. Tapemark Major Business
Table 76. Tapemark Transmucosal Drug Delivery Product and Solutions
Table 77. Tapemark Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. tesa Labtec GmbH Corporate Information, Head Office, and Major Competitors
Table 79. tesa Labtec GmbH Major Business
Table 80. tesa Labtec GmbH Transmucosal Drug Delivery Product and Solutions
Table 81. tesa Labtec GmbH Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. TEVA Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors
Table 83. TEVA Pharmaceutical Industries Ltd. Major Business
Table 84. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product and Solutions
Table 85. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Zosano Pharma Corporate Information, Head Office, and Major Competitors
Table 87. Zosano Pharma Major Business
Table 88. Zosano Pharma Transmucosal Drug Delivery Product and Solutions
Table 89. Zosano Pharma Transmucosal Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Global Transmucosal Drug Delivery Revenue (USD Million) by Players (2019-2021)
Table 91. Global Transmucosal Drug Delivery Revenue Share by Players (2019-2021)
Table 92. Breakdown of Transmucosal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Transmucosal Drug Delivery Players Head Office, Products and Services Provided
Table 94. Transmucosal Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 95. Transmucosal Drug Delivery New Entrants and Expansion Plans
Table 96. Global Transmucosal Drug Delivery Revenue (USD Million) by Type (2016-2021)
Table 97. Global Transmucosal Drug Delivery Revenue Share by Type (2016-2021)
Table 98. Global Transmucosal Drug Delivery Revenue Forecast by Type (2021-2026)
Table 99. Global Transmucosal Drug Delivery Revenue by Application (2016-2021)
Table 100. Global Transmucosal Drug Delivery Revenue Forecast by Application (2021-2026)
Table 101. North America Transmucosal Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 102. North America Transmucosal Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 103. North America Transmucosal Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 104. North America Transmucosal Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 105. North America Transmucosal Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 106. North America Transmucosal Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 107. Europe Transmucosal Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 108. Europe Transmucosal Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 109. Europe Transmucosal Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 110. Europe Transmucosal Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 111. Europe Transmucosal Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 112. Europe Transmucosal Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 113. Asia-Pacific Transmucosal Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 114. Asia-Pacific Transmucosal Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 115. Asia-Pacific Transmucosal Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 116. Asia-Pacific Transmucosal Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 117. Asia-Pacific Transmucosal Drug Delivery Revenue by Region (2016-2021) & (USD Million)
Table 118. Asia-Pacific Transmucosal Drug Delivery Revenue by Region (2021-2026) & (USD Million)
Table 119. South America Transmucosal Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 120. South America Transmucosal Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 121. South America Transmucosal Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 122. South America Transmucosal Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 123. South America Transmucosal Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 124. South America Transmucosal Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Transmucosal Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 126. Middle East & Africa Transmucosal Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 127. Middle East & Africa Transmucosal Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 128. Middle East & Africa Transmucosal Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 129. Middle East & Africa Transmucosal Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 130. Middle East & Africa Transmucosal Drug Delivery Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Transmucosal Drug Delivery Picture
Figure 2. Global Transmucosal Drug Delivery Revenue Market Share by Type in 2020
Figure 3. Passive Transdermal Drug Delivery
Figure 4. Active Transdermal Drug Delivery
Figure 5. Transmucosal Drug Delivery Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Others Picture
Figure 9. Global Transmucosal Drug Delivery Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Transmucosal Drug Delivery Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Transmucosal Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 12. Global Transmucosal Drug Delivery Revenue Market Share by Region in 2020
Figure 13. North America Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Transmucosal Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Transmucosal Drug Delivery Market Drivers
Figure 19. Transmucosal Drug Delivery Market Restraints
Figure 20. Transmucosal Drug Delivery Market Trends
Figure 21. 3M Pharmaceuticals Recent Developments and Future Plans
Figure 22. Acrux Limited Recent Developments and Future Plans
Figure 23. ALZA Corporation Recent Developments and Future Plans
Figure 24. Antares Pharma, Inc. Recent Developments and Future Plans
Figure 25. Apricus BioSciences, Inc Recent Developments and Future Plans
Figure 26. Aveva Drug Delivery Systems Recent Developments and Future Plans
Figure 27. Corium International, Inc Recent Developments and Future Plans
Figure 28. DURECT Corporation Recent Developments and Future Plans
Figure 29. Generex Biotechnology Corporation Recent Developments and Future Plans
Figure 30. Inovio Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 31. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments and Future Plans
Figure 32. MedPharm LTD Recent Developments and Future Plans
Figure 33. Mylan, Inc. Recent Developments and Future Plans
Figure 34. Nemaura Pharma Ltd Recent Developments and Future Plans
Figure 35. Nitto Denko Corporation Recent Developments and Future Plans
Figure 36. Noven Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 37. Pantec Biosolutions AG Recent Developments and Future Plans
Figure 38. Tapemark Recent Developments and Future Plans
Figure 39. tesa Labtec GmbH Recent Developments and Future Plans
Figure 40. TEVA Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Figure 41. Zosano Pharma Recent Developments and Future Plans
Figure 42. Global Transmucosal Drug Delivery Revenue Share by Players in 2020
Figure 43. Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players Transmucosal Drug Delivery Revenue Market Share in 2020
Figure 45. Global Top 10 Players Transmucosal Drug Delivery Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global Transmucosal Drug Delivery Revenue Share by Type in 2020
Figure 48. Global Transmucosal Drug Delivery Market Share Forecast by Type (2021-2026)
Figure 49. Global Transmucosal Drug Delivery Revenue Share by Application in 2020
Figure 50. Global Transmucosal Drug Delivery Market Share Forecast by Application (2021-2026)
Figure 51. North America Transmucosal Drug Delivery Sales Market Share by Type (2016-2026)
Figure 52. North America Transmucosal Drug Delivery Sales Market Share by Application (2016-2026)
Figure 53. North America Transmucosal Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 54. United States Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe Transmucosal Drug Delivery Sales Market Share by Type (2016-2026)
Figure 58. Europe Transmucosal Drug Delivery Sales Market Share by Application (2016-2026)
Figure 59. Europe Transmucosal Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 60. Germany Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific Transmucosal Drug Delivery Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific Transmucosal Drug Delivery Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Transmucosal Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 68. China Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America Transmucosal Drug Delivery Sales Market Share by Type (2016-2026)
Figure 75. South America Transmucosal Drug Delivery Sales Market Share by Application (2016-2026)
Figure 76. South America Transmucosal Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa Transmucosal Drug Delivery Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa Transmucosal Drug Delivery Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa Transmucosal Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 82. Turkey Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE Transmucosal Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source

---